论文部分内容阅读
目的观察西替利嗪联合卡介菌多糖核酸治疗儿童过敏性紫癜的疗效。方法儿童过敏性紫癜87例随机分为两组,A组47例口服西替利嗪联合卡介菌多糖核酸肌内注射治疗,B组40例采用以西替利嗪为主的常规治疗,比较两组患儿过敏性紫癜皮损及其他系统症状消退情况。结果 A组有效率(87.23%)优于B组(70.00%)(P<0.05)。结论西替利嗪联合卡介菌多糖核酸治疗儿童过敏性紫癜疗效确切。
Objective To observe the curative effect of cetirizine combined with BCG polysaccharide nucleic acid in the treatment of Henoch-Schonlein purpura in children. Methods 87 cases of children with Henoch-Schonlein purpura were randomly divided into two groups, A group of 47 cases of oral cetirizine plus BCG polysaccharide nucleic acid intramuscular injection, 40 cases of B group with cetirizine-based conventional treatment, compared with two Children with allergic purpura skin lesions and other symptoms subsided. Results The effective rate of group A (87.23%) was better than that of group B (70.00%) (P <0.05). Conclusion Cetirizine combined with BCG polysaccharide nucleic acid treatment of children with anaphylactoid purpura curative effect.